Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Findings from D. Seely and co-researchers advance knowledge in breast cancer
March 27th, 2008
According to recent research from Toronto, Canada, "Despite the recommendation of the Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative, little research has been published on the widely used,herbal compound Essiac (R). We aimed to address this deficiency by conducting a series of assays to determine some of the purported activities of Essiac (R) in vitro." "The activity of Essiac (R) was measured using established assays to assess anti-oxidant, fibrinolytic, anti-microbial, anti-inflammatory, immune modulation, cells-pecific cytotoxicity, and impact on cytochrome P450 (CYP450) enzyme pathways. Essiac (R) exhibited significant...
Source: Women's Health Weekly (2008-03-27)
|
